TargetMol

Z-FA-FMK

Product Code:
 
TAR-T6738
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6738-1mg1mg£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-1mL1 mL * 10 mM (in DMSO)£213.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-5mg5mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-10mg10mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-25mg25mg£455.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-50mg50mg£595.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6738-100mg100mg£817.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Z-FA-FMK can irreversibly inhibit cysteine protease and also inhibit effector caspases.
CAS:
197855-65-5
Formula:
C21H23FN2O4
Molecular Weight:
386.423
Pathway:
Microbiology/Virology; Proteases/Proteasome
Purity:
0.9968
SMILES:
CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF
Target:
SARS-CoV; Cysteine Protease

References

Schotte P, et al. J Biol Chem. 2001, 276(24), 21153-21157. Rasnick D. Anal Biochem. 1985, 149(2), 461-465. Kim M, et al. Antivir Ther. 2010, 15(6), 897-905. Lawrence CP, et al. J Immunol. 2006, 177(6), 3827-3836. van Noorden CJ, et al. Biochem Biophys Res Commun. 1991, 178(1), 178-184.